Results for tag: "Trichomoniasis Drug"

The Trichomoniasis Drug market is a subset of the Sexual and Reproductive Health Drugs market. It is composed of drugs used to treat trichomoniasis, a sexually transmitted infection caused by the parasite Trichomonas vaginalis. Treatment typically involves a single dose of an antibiotic, such as metronidazole or tinidazole. These drugs are available in both oral and topical forms, and are typically prescribed by a doctor. Trichomoniasis is a common infection, and the prevalence of the disease is increasing in many parts of the world. As such, the Trichomoniasis Drug market is an important part of the Sexual and Reproductive Health Drugs market. Some companies in the Trichomoniasis Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Bayer. Show Less Read more